These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
856 related articles for article (PubMed ID: 17899499)
1. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]. Rieger CT; Dittmer M; Ostermann H Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499 [TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411 [TBL] [Abstract][Full Text] [Related]
3. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R; Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465 [TBL] [Abstract][Full Text] [Related]
4. Treatment of systemic fungal infections with liposomal amphotericin B. Lopez-Berestein G; Bodey GP; Fainstein V; Keating M; Frankel LS; Zeluff B; Gentry L; Mehta K Arch Intern Med; 1989 Nov; 149(11):2533-6. PubMed ID: 2818111 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries. Ullmann AJ; Sanz MA; Tramarin A; Barnes RA; Wu W; Gerlach BA; Krobot KJ; Gerth WC; Clin Infect Dis; 2006 Aug; 43(4):e29-38. PubMed ID: 16838223 [TBL] [Abstract][Full Text] [Related]
6. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections. Hooshmand-Rad R; Reed MD; Chu A; Gotz V; Morris JA; Weinberg J; Dominguez EA Clin Ther; 2004 Oct; 26(10):1652-62. PubMed ID: 15598482 [TBL] [Abstract][Full Text] [Related]
7. Use of liposomal amphotericin B in bone marrow transplant. Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256 [TBL] [Abstract][Full Text] [Related]
8. Lipid formulations of amphotericin B. Dix SP; Andriole VT Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516 [TBL] [Abstract][Full Text] [Related]
9. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India. Jadhav MP; Shinde VM; Chandrakala S; Jijina F; Menon H; Arora B; Kurkure PA; Parikh PM; Kshirsagar NA Indian J Cancer; 2012; 49(1):107-13. PubMed ID: 22842177 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366 [TBL] [Abstract][Full Text] [Related]
11. Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B. Krüger WH; Rüssmann B; de Wit M; Kröger N; Renges H; Sobottka I; Zander AR Acta Haematol; 2005; 113(2):104-8. PubMed ID: 15802888 [TBL] [Abstract][Full Text] [Related]
12. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients. Noskin G; Pietrelli L; Gurwith M; Bowden R Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847 [TBL] [Abstract][Full Text] [Related]
13. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment. Alvarez-Lerma F; Soriano MC; Rodríguez M; Catalán M; Llorente AM; Vidart N; Garitacelaya M; Maraví E; Fernández E; Alvarado F; López M; Alvarez-Sánchez B; Espinosa J; Quintana E; Rev Esp Quimioter; 2012 Sep; 25(3):206-15. PubMed ID: 22987267 [TBL] [Abstract][Full Text] [Related]
14. Liposomal amphotericin B for the treatment of severe fungal infection. Michaud D Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230 [TBL] [Abstract][Full Text] [Related]
15. Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B. Krüger WH; Kröger N; Rüssmann B; Renges H; Kabisch H; Zander AR Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S10-3. PubMed ID: 9916623 [TBL] [Abstract][Full Text] [Related]
16. [Impact on renal function of an early switch from conventional to liposomal amphotericin B formulation in the empirical treatment of fungal infections]. Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Monchecourt F; Mahi L; Deray G Med Mal Infect; 2008 Apr; 38(4):208-14. PubMed ID: 18191521 [TBL] [Abstract][Full Text] [Related]
17. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Ng TT; Denning DW Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054 [TBL] [Abstract][Full Text] [Related]
18. [Safety of liposomal amphotericin B in patients with high risk of nephrotoxicity]. González E; Rada MA; Lumbreras C; Ramos JT; Aguado JM Enferm Infecc Microbiol Clin; 2000 Apr; 18(4):162-4. PubMed ID: 10932392 [TBL] [Abstract][Full Text] [Related]
19. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate. Maharom P; Thamlikitkul V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252 [TBL] [Abstract][Full Text] [Related]
20. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A; Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]